| pubmed-article:16703499 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16703499 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
| pubmed-article:16703499 | lifeskim:mentions | umls-concept:C0243005 | lld:lifeskim |
| pubmed-article:16703499 | lifeskim:mentions | umls-concept:C0006118 | lld:lifeskim |
| pubmed-article:16703499 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:16703499 | lifeskim:mentions | umls-concept:C0008405 | lld:lifeskim |
| pubmed-article:16703499 | lifeskim:mentions | umls-concept:C0851346 | lld:lifeskim |
| pubmed-article:16703499 | lifeskim:mentions | umls-concept:C0178874 | lld:lifeskim |
| pubmed-article:16703499 | lifeskim:mentions | umls-concept:C0033204 | lld:lifeskim |
| pubmed-article:16703499 | lifeskim:mentions | umls-concept:C0205345 | lld:lifeskim |
| pubmed-article:16703499 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:16703499 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:16703499 | pubmed:dateCreated | 2006-6-1 | lld:pubmed |
| pubmed-article:16703499 | pubmed:abstractText | To determine the relative signal intensity ratios of choline (Cho), phosphocreatine (CR) and N-acetyl-aspartate (NAA) in MR spectroscopic imaging (proton-MRSI) for differentiating progressive tumors (PT) from non-progressive tumors (nPT) in follow-up and treatment planning of gliomas. Threshold values to indicate the probability of a progressive tumor were also calculated. | lld:pubmed |
| pubmed-article:16703499 | pubmed:language | ger | lld:pubmed |
| pubmed-article:16703499 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16703499 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16703499 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16703499 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16703499 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16703499 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16703499 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16703499 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16703499 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16703499 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:16703499 | pubmed:issn | 1438-9029 | lld:pubmed |
| pubmed-article:16703499 | pubmed:author | pubmed-author:BachertPP | lld:pubmed |
| pubmed-article:16703499 | pubmed:author | pubmed-author:DebusJJ | lld:pubmed |
| pubmed-article:16703499 | pubmed:author | pubmed-author:Schulz-Ertner... | lld:pubmed |
| pubmed-article:16703499 | pubmed:author | pubmed-author:KauczorH-UHU | lld:pubmed |
| pubmed-article:16703499 | pubmed:author | pubmed-author:WeberM-AMA | lld:pubmed |
| pubmed-article:16703499 | pubmed:author | pubmed-author:LichyM PMP | lld:pubmed |
| pubmed-article:16703499 | pubmed:author | pubmed-author:SchlemmerH-PH... | lld:pubmed |
| pubmed-article:16703499 | pubmed:author | pubmed-author:HamprechtFF | lld:pubmed |
| pubmed-article:16703499 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16703499 | pubmed:volume | 178 | lld:pubmed |
| pubmed-article:16703499 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16703499 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16703499 | pubmed:pagination | 627-33 | lld:pubmed |
| pubmed-article:16703499 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:meshHeading | pubmed-meshheading:16703499... | lld:pubmed |
| pubmed-article:16703499 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16703499 | pubmed:articleTitle | [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors]. | lld:pubmed |
| pubmed-article:16703499 | pubmed:affiliation | Abteilung für Radiologische Diagnostik, Universität Tübingen. matthias.lichy@med.uni-tuebingen.de | lld:pubmed |
| pubmed-article:16703499 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16703499 | pubmed:publicationType | English Abstract | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16703499 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16703499 | lld:pubmed |
